Compare MSCI & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MSCI | CAH |
|---|---|---|
| Founded | 1998 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.6B | 49.4B |
| IPO Year | 2007 | N/A |
| Metric | MSCI | CAH |
|---|---|---|
| Price | $581.08 | $207.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 12 |
| Target Price | ★ $642.63 | $200.25 |
| AVG Volume (30 Days) | 703.5K | ★ 2.3M |
| Earning Date | 01-28-2026 | 01-29-2026 |
| Dividend Yield | ★ 1.24% | 0.98% |
| EPS Growth | 3.54 | ★ 27.25 |
| EPS | ★ 15.77 | 6.63 |
| Revenue | $3,055,440,000.00 | ★ $234,310,000,000.00 |
| Revenue This Year | $11.86 | $16.60 |
| Revenue Next Year | $9.23 | $8.26 |
| P/E Ratio | $36.88 | ★ $31.32 |
| Revenue Growth | ★ 9.02 | 4.39 |
| 52 Week Low | $486.74 | $117.53 |
| 52 Week High | $634.99 | $214.93 |
| Indicator | MSCI | CAH |
|---|---|---|
| Relative Strength Index (RSI) | 67.34 | 67.77 |
| Support Level | $559.27 | $195.54 |
| Resistance Level | $556.65 | $200.83 |
| Average True Range (ATR) | 10.21 | 2.73 |
| MACD | 4.52 | -0.02 |
| Stochastic Oscillator | 92.82 | 88.62 |
MSCI has described its mission as enabling investors to build better portfolios for a better world. MSCI's largest and most profitable segment is its index segment, where it provides benchmarking to asset managers and asset owners. MSCI boasts about $17 trillion in benchmarked assets, including over $2.2 trillion in ETF assets linked to MSCI indexes. The MSCI analytics segment provides portfolio management and risk management analytics software to asset managers and asset owners. In its sustainability and climate segment, MSCI provides ESG data to the investment industry. In private assets, MSCI provides real restate reporting, market data, benchmarking, and analytics to investors and real estate managers.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.